Your browser doesn't support javascript.
loading
Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19).
Canavati, Christina; Siam, Ahmad; Labes, Sapir; Trabelsi, Nirit; Regev, Eshcar; Parnasa, Elchanan; Barhoum, Barhoum; Magadle, Nur; Perzon, Ofer; Braun, Maya; Mor-Shaked, Hagar; Schueler-Furman, Ora; Tabach, Yuval; Mevorach, Dror.
Afiliação
  • Canavati C; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada (C.C., S.L., M.B., Y.T.), Jerusalem, Israel.
  • Siam A; Hebrew University-Hadassah Faculty of Medicine (C.C., S.L., H.M.-S., Y.T., D.M.), Jerusalem, Israel.
  • Labes S; The Wohl Institute for Translational Medicine (A.S., E.R., E.P., B.B., N.M., O.P., D.M.)., Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Trabelsi N; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada (C.C., S.L., M.B., Y.T.), Jerusalem, Israel.
  • Regev E; Hebrew University-Hadassah Faculty of Medicine (C.C., S.L., H.M.-S., Y.T., D.M.), Jerusalem, Israel.
  • Parnasa E; Department of Microbiology and Molecular Genetics, IMRIC (N.T., O.S.F.), Jerusalem, Israel.
  • Barhoum B; The Wohl Institute for Translational Medicine (A.S., E.R., E.P., B.B., N.M., O.P., D.M.)., Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Magadle N; The Wohl Institute for Translational Medicine (A.S., E.R., E.P., B.B., N.M., O.P., D.M.)., Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Perzon O; The Wohl Institute for Translational Medicine (A.S., E.R., E.P., B.B., N.M., O.P., D.M.)., Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Braun M; The Wohl Institute for Translational Medicine (A.S., E.R., E.P., B.B., N.M., O.P., D.M.)., Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Mor-Shaked H; The Wohl Institute for Translational Medicine (A.S., E.R., E.P., B.B., N.M., O.P., D.M.)., Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Schueler-Furman O; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada (C.C., S.L., M.B., Y.T.), Jerusalem, Israel.
  • Tabach Y; Hebrew University-Hadassah Faculty of Medicine (C.C., S.L., H.M.-S., Y.T., D.M.), Jerusalem, Israel.
  • Mevorach D; Department of Genetics, Hadassah Medical Center, Jerusalem, Israel (H.M.-S.).
Circulation ; 149(3): 270-273, 2024 01 16.
Article em En | MEDLINE | ID: mdl-38227712
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 / Miocardite Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 / Miocardite Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article